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H2S and NO cooperatively regulate vascular tone
by activating a neuroendocrine HNO–TRPA1–CGRP
signalling pathway
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Marcelo A. Martı´7,10, Fabio Doctorovich7, Edward D. Ho¨gesta¨tt11, Peter M. Zygmunt11,
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Nitroxyl (HNO) is a redox sibling of nitric oxide (NO) that targets distinct signalling pathways
with pharmacological endpoints of high signiﬁcance in the treatment of heart failure.
Beneﬁcial HNO effects depend, in part, on its ability to release calcitonin gene-related peptide
(CGRP) through an unidentiﬁed mechanism. Here we propose that HNO is generated as a
result of the reaction of the two gasotransmitters NO and H2S. We show that H2S and NO
production colocalizes with transient receptor potential channel A1 (TRPA1), and that HNO
activates the sensory chemoreceptor channel TRPA1 via formation of amino-terminal
disulphide bonds, which results in sustained calcium inﬂux. As a consequence, CGRP is
released, which induces local and systemic vasodilation. H2S-evoked vasodilatatory effects
largely depend on NO production and activation of HNO–TRPA1–CGRP pathway. We propose
that this neuroendocrine HNO–TRPA1–CGRP signalling pathway constitutes an essential
element for the control of vascular tone throughout the cardiovascular system.
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N
itroxyl, HNO, is the one-electron-reduced sibling of nitric
oxide (NO) but follows an entirely separate signalling
pathway1,2. HNO exerts systemic cardiovascular effects by
releasing calcitonin gene-related peptide (CGRP) that combines
general vasodilation with positive inotropic and lusitropic
actions3,4. HNO donors, thus, provide a great promise for the
treatment of heart failure, avoiding the problem of nitrate
tolerance4–6. However, biochemical pathway(s) for HNO
generation as well as the physiological mechanism of its CGRP
releasing ability are still unknown, whereas abundant CGRP
stores do exist inside ubiquitous sensory nerve ﬁbres7–9. In this
study, we aimed at understanding the actual biochemical pathway
for HNO-induced CGRP release and at ﬁnding the actual source
of HNO in vivo.
Recently, a new gaseous signalling molecule emerged, hydro-
gen sulphide (H2S), with physiological endpoints similar to that
of NO10–13. Some studies even suggested that the effects of H2S
and NO are mutually interdependent13–16. Elegant work on
vascular endothelium and smooth muscle recently proposed a
parallel formation of NO and H2S, the former entering the
guanylyl cyclase pathway, the latter inhibiting phosphodiesterase
5, together thus stabilizing the level of vasorelaxant cyclic GMP14.
A direct reaction of NO with thiols is too slow to be of
physiological relevance17,18, whereas a direct interaction between
NO and H2S has not yet been studied. We hypothesized, however,
that the two gasotransmitters could enter a redox reaction with
each other, which results in HNO formation—a potential way to
intracellular HNO generation, if the H2S and NO producing
enzymes were co-expressed. Knowing that the primary targets
for HNO are thiols1,2 and the reason for its cardioprotective
effect is CGRP release3,4, we hypothesized that HNO acts as an
endogenous agonist of transient receptor potential channel A1
(TRPA1), a potential target for H2S (ref. 19) that is expressed in
sensory nerve ﬁbres and activated by numerous endogenous
metabolites and environmental irritants20–22 through covalent
modiﬁcation of particular cysteine residues23,24, leading to para-
and/or endocrine CGRP release and to local or general
vasodilation, respectively.
Results
HNO activates TRPA1 in cells and sensory neurons. The effects
of HNO on Chinese hamster ovary cells stably expressing
mTRPA1 were examined by whole-cell voltage clamp. Angeli’s
salt (AS) was used as a donor of HNO (Fig. 1). AS decomposes in
neutral buffer to give equimolar amounts of nitrite and HNO
with a half-life of about 5min at 37 C (ref. 25). In addition, HNO
dimerizes rapidly (8 106M 1 s 1) (ref. 25) with elimination of
water to give inert N2O. Considering the inherent delays in the
various experimental set-ups, this implies that the actual
concentration of HNO in physiological buffer at the time of
measurement was lower (less than half) than that of AS initially
dissolved and explains a relatively high dose of AS required to
induce an effect. Sixty-second exposures to (initially) 400 mM
AS-evoked large sustained inward currents, which could be
repeatedly blocked by the TRPA1 channel antagonist HC030031
(Fig. 1b). Control treatment with decomposed AS showed no
effect (Supplementary Fig. 1). Measuring ramp currents ( 100
to þ 100mV in 500ms), we observed that AS induced an out-
wardly rectifying current–voltage relationship (Fig. 1b), while
decomposed AS was ineffective.
To conﬁrm the observed effects in native sensory neurons,
Ca2þ inﬂux was measured in cultured, Fura-2-stained dorsal root
ganglion (DRG) neurons of wild-type and TRPA1 /
mice. Forty-ﬁve-second exposures to AS caused an increase
in intracellular Ca2þ in 28 % of wild-type cells (Fig. 1c).
The correlation of the cells responding to AS with responses to
the prototypic TRPA1 agonist allyl isothiocyanate (AITC 100 mM,
r¼ 0.625) strongly implied the involvement of TRPA1. This
was supported by a complete block of AS-evoked Ca2þ
increase under HC030031 (Fig. 1d). Wash-out of HC030031
caused an immediate recovery of the previously suppressed AS
response, similar to the repeated inhibition and recovery observed
in patch clamp experiments (Fig. 1b), suggesting that the
activating modiﬁcations induced by HNO treatment were
sustained. In cells prepared from TRPA1 / mice, AS, like
AITC, had no effect (Fig. 1d), proving that TRPA1 was the
receptor channel activated by HNO. In wild-type mice, there was
no effect of decomposed AS (Fig. 1d) or of AS applied in Ca2þ -
free external solution excluding intracellular store depletion
(Fig. 1b).
The use of a pure NO donor (DEA NONOate) at doses similar
to HNO had no effect on intracellular Ca2þ (Fig. 1d). However,
high concentrations of NO did induce slow Ca2þ entry,
indicative of non-physiological formation of high levels of N2O3
acting as an S-nitrosating agent17 (Supplementary Fig. 2a). In fact,
the use of a direct S-nitrosating agent, SNAP, induced reversible
Ca2þ inﬂux (at concentrations 41mM), with the effect being
quickly abolished when SNAP was removed (Supplementary
Fig. 2b), clearly distinguishing it from sustained Ca2þ inﬂux
observed with AS.
HNO-induced disulphide formation on TRPA1. hTRPA1 is
rich in cysteine residues and C621, C641 and C665 of the N
terminus are responsible for electrophilic activation23. To test
whether these speciﬁc cysteine residues play a role, experiments
were performed on HEK293 cells expressing hTRPA1 and
cysteine- and lysine-neutralized mutants, hTRPA1-C621S/
C641S/C665S (hTRPA1-3C) and hTRPA1-C621S/C641S/C665S/
K710R (hTRPA1-3CK). AS had no effect on non-transfected
HEK cells but induced large responses in hTRPA1-transfected
cells. Cells expressing hTRPA1-3CK or hTRPA1-3C did not
respond to AS at all (Fig. 2a). Although many TRPA1 agonists at
higher concentrations also activate TRPV1 (ref. 26), no responses
could be observed in experiments on hTRPV1-transfected HEK
cells (Supplementary Fig. 2c).
Providing that the observed effects originate from disulphide
formation, the reducing agent dithiothreitol (DTT) should
interfere with the outlasting TRPA1 responses. Indeed, the decay
of the AS responses was considerably accelerated when 5mM
DTT was externally applied, and the downward inﬂection upon
DTT onset almost restored intracellular Ca2þ to baseline level
within 10min (Supplementary Fig. 3). HC030031 applied after
AS caused similar effects, however, after its removal, a rebound
rise in intracellular Ca2þ occurred, conﬁrming a temporary block
in presence of a sustained TRPA1 modiﬁcation by HNO.
The outlasting AS-induced inward currents were instantly
reversed by the administration of 5mM DTT and did not recur
upon its washout (Fig. 2b). When the cells were subsequently
re-exposed to AS, the responses were smaller (62.5% of ﬁrst
response). These currents could be blocked by HC030031 only for
the duration of its application, and DTT again deactivated the
recurred inward current completely.
Formation of disulphides upon HNO stimulation of TRPA1
was further supported using a modiﬁed biotin-switch assay
(Fig. 2c) on V5-poly-His-tagged mTRPA1 expressed and puriﬁed
from HEK cells (Supplementary Fig. 4a–d). The protein that was
exposed to HNO provided positive staining in a concentration-
dependent manner while the control or the iodoacetamide
(IA)-pretreated protein exposed to HNO showed no disulphide
bond formation (Fig. 2c).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5381
2 NATURE COMMUNICATIONS | 5:4381 | DOI: 10.1038/ncomms5381 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
To identify the reaction site, a custom-made synthetic peptide
consisting of 64 amino acids of the hTRPA1 N terminus,
including the three critical and three neighbouring cysteine
residues, was analysed by MALDI-TOF mass spectrometry (MS)
(Fig. 2d,e, Supplementary Fig. 4e). MS analysis revealed
disulphide formation between the critical Cys 621 and the
neighbouring Cys 633 as well as between Cys 651 and the critical
Cys 665 (Fig. 2f).
Formation of disulphides by HNO would go step-wise, with
initial formation of a (hydroxyamino)sulfanyl derivative at critical
cysteine residues and then fast subsequent reaction with another
cysteine in vicinity, leading to substantial allosteric deformation
and channel opening (Fig. 2g). Such disulphide bonds may
account for the observed slow deactivation of TRPA1 after AS
treatment. Ab initio structure prediction of a 200 amino acid long
N-terminal sequence covering important cysteine residues
(Fig. 2h) revealed that the cysteine residues 665 and 651 are
connected by a ﬂexible loop and could easily get into each other’s
vicinity, a condition that would facilitate disulphide bond
formation. In addition, disulphide bond formation is facilitated
between the Cys 633 and 621, where the atom distance is
estimated to be 4.4 Å.
TRPA1 is responsible for HNO-induced release of CGRP. Next
we tested how HNO-induced TRPA1 activation affects CGRP
release from isolated tissues. CGRP is typically released from
polymodal A-delta and C-ﬁber afferents27. At ﬁrst, the release of
CGRP from rat dura mater exposed in a hemisected skull
preparation was measured in 5-min samples of incubation ﬂuid
using enzyme immunoassays (Fig. 3a–c). Exposure to AS induced
an increase in CGRP release (by 46.4±5.3 pgml 1) while DEA
NONOate was ineffective (Fig. 3b,c) conﬁrming previous
observations of distinct biochemical pathways that these two
congeners enter downstream of nitric oxide synthase (NOS)1–4.
HC030031 signiﬁcantly inhibited the AS-evoked responses
(18.1±4.6 pgml 1, Fig. 3a,c).
We also added evidence from another species and innervation
territory measuring CGRP release from sciatic nerve (Fig. 3d) and
cranial dura mater (Fig. 3e) of wild-type and TRPA1 / mice.
In both preparations, HC030031 had the same inhibitory effects
(Fig. 3f) as observed in rat (Fig. 3a,c) but preparations taken from
congenic TRPA1 / mice did not respond to AS stimulation at
all (Fig. 3f). These results conﬁrm that HNO-induced CGRP
release is selectively mediated via TRPA1 receptor channels.
CGRP is a potent vasodilator contributing to overall cardiovas-
cular homeostasis7. It is also released from trigeminal nerve ﬁbres
accompanying meningeal blood vessels and plays an established
role in migraine8. In anaesthetized rats, topically applied AS
(60 nmol) induced an increase in meningeal blood ﬂow (recorded
by laser Doppler ﬂowmetry) by 24 %, while co-application of
HC0300301 (50mM) reduced this response by 64% (Fig. 4a). Co-
application of CGRP receptor antagonist, CGRP8–37, also inhibited
the AS-evoked dilatation, although not as effectively as TRPA1
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Figure 1 | HNO released by AS activates TRPA1 channels. (a) Treatment with AS (300 mM) but not DEA NONOate (100mM) increased ﬂuorescence
in sensory neurons (DRG) incubated with CuBOT1, a ﬂuorescent dye for nitroxyl detection (analysis of variance following honestly signiﬁcant difference
post hoc test Po0.001; P¼0.97, respectively; n¼ 200 per group; scale bar, 40mm). (b) AS (400mM, 60 s) evoked inward currents in Chinese hamster
ovary cells (n¼ 7) expressing mTRPA1, which could be repeatedly blocked by HC030031 (50mM, 10 s). Inset: Ramp currents through TRPA1 before
(control, black) and during application of either decomposed AS (grey) or 400 mM AS (red). (c) Ca2þ inﬂux (mean±s.e.m.) in DRG neurons of C57Bl/6
mice treated with AS (300mM, 45 s), AITC (100mM, 20 s) and capsaicin (0.3mM, 10 s at 4-min intervals) and corresponding representative pseudocolor
images (scale bar, 80mm). (d) AS effects are abolished by application of HC030031 (50 mM) or decomposed AS and absent in TRPA1 / mice.
DEA NONOate (100mM, 45 s) caused no effect. Data represent mean±s.e.m., n¼ 300 DRG neurons for each group.
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Figure 2 | HNO activates TRPA1 via disulphide bond formation. (a) AS (300 mM, 45 s) increases intracellular Ca2þ in hTRPA1-transfected HEK cells but
not in cells expressing hTRPA1-3C; mean±s.e.m., n¼ 250 cells for each group. Representative pseudocolor images (scale bar, 100mm). (b) AS-evoked
inward currents (n¼ 7) can be reversed by application of DTT (5mM, 60 s), or temporarily blocked by HC030031 (50mM, 10 s). Inset: AS (400mM)-
evoked peak inward currents are signiﬁcantly reduced by HC030031 or DTT (analysis of variance following honestly signiﬁcant difference post hoc test,
Po0.001 each; n¼ 7; error bars represent s.e.m.). (c) Detection of disulphide bond formation on puriﬁed mTRPA1 channel protein (100mM) treated with
AS, using modiﬁed biotin-switch assay. Lane 1: TRPA1 treated with 1.5mM AS, lane 2: TRPA1 treated with 0.5mM AS, lane 3: untreated protein, lane 4:
TRPA1 pretreated with IA and then treated with 1.5mM AS. (d,e) MALDI-TOF MS of AS-treated TRPA1 synthetic peptide. Peptide fragments containing
cysteine residues differ in AS-treated (black, d) and control (red, e) samples. The same fragmenting pattern is observed in both cases but with m/z of the
AS-treated fragments being shifted towards lower masses (by m/z 116¼ 2IAþ 2H), indicating formation of disulphides. (f) Amino-acid sequence of
synthetic peptide used in the study to mimic the part of hTRPA1 N terminus with critical, that is, activating cysteines and a rationale for deciphering
disulphide bond positions based on observed fragments. Yellow marked cysteine residues form disulphide bonds and red cysteine residues are found to be
modiﬁed by IA even after exposure to AS. (g) Schematic model of TRPA1 with cysteine-rich region (red dots) and formation of disulphide bonds causing
major conformational changes. Chemical structure (bottom) of two cysteine-SH residues reacting with HNO to form hydroxylamine (NH2OH) and a
disulphide bond and causing conformational change. (h) Ab initio model of the 200 amino acid long polypeptide chain of the N terminus of hTRPA1
displaying ﬁve essential cysteine residues and two indicated disulphides (dotted lines).
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channel blockade, most likely due to modiﬁcation of the inhibitory
peptide by HNO (Supplementary Fig. 5).
To assess to what extent the systemic hypotensive effect of HNO
depends on TRPA1, the mean arterial blood pressure (MAP) of
anesthetized mice was measured. Mice were injected intravenously
with freshly dissolved AS (61mg kg 1 body weight) in saline
solution (pH 7.0). AS induced a drop of MAP by 18.8±1.2mmHg
in wild type, but only 8.8±0.9mmHg in TRPA1 / mice
(Fig. 4b), indicating that a signiﬁcant proportion of the
vasodilatory effect of HNO is mediated by TRPA1.
CGRP release from sensory nerve ﬁbres does not necessarily
require action potential discharge; subliminal depolarization is
sufﬁcient9. Nonetheless, strong activation of TRPA1-expressing
peptidergic nerve ﬁbres should evoke pain. This was tested in
human volunteers by double-blinded intracutaneos injection of
AS (0.7mmol, Fig. 4c). Injections of AS caused an immediate
burning pain declining over B7.5min with a mean maximum
rating of 3.6±0.4 (on a numerical rating scale 0–10, n¼ 6).
Decomposed AS and DEA NONOate were neither rated as
painful nor as itching (Fig. 4d). Although TRPA1 is not activated
by noxious heat in heterologous expression systems, its activation
by cinnamaldehyde causes heat hyperalgesia in humans28. In our
experiments, injection of AS but not of DEA NONOate or
decomposed AS increased the pain ratings (from 2.6±0.6 to
4.3±0.7, Po0.001, analysis of variance and least signiﬁcant
difference) in response to noxious heat (5 s, 47 C). In addition,
injection of AS into the skin of the volar forearm induced a large
axon-reﬂex erythema (Fig. 4c) visualized by laser Doppler
scanning of superﬁcial blood ﬂow (Fig. 4e, Supplementary
Fig. 6a), which was not affected by the pre-administration of
Clemastine, an H1 histaminic receptor blocker, indicating that
the AS-induced vasodilation is not due to mast cell degranulation
(Supplementary Fig. 6b,c).
Generation of HNO from NO and H2S. The cross-talk of H2S
and NO has been suggested14–16 but the actual direct reaction of
NO with H2S has not been studied before. The reaction of NO
and H2S solutions was initially probed amperometrically using
H2S and NO selective electrodes. The drop of the H2S electrode
response upon addition of gaseous NO suggested immediate H2S
consumption under aerobic conditions (Fig. 5a) and the apparent
rate of this reaction remained unchanged even in the presence
of 20-fold excess of glutathione in anoxic conditions
(Supplementary Fig. 7a). In parallel, NO release from DEA
NONOate was prevented when H2S was present in the solution
(Fig. 5b). Both, the addition of NO to degassed H2S solution, or
H2S to NO solution led to immediate sulphur/polysulphide
formation suggesting that H2S was oxidized and consequently
NO was reduced.
The ultimate proof for the in vitro HNO formation came
from the recently developed HNO-selective electrode29. The
results show that a rate of HNO production through an anaerobic
reaction between NO and H2S is orders of magnitude faster
than for any known HNO donor (Fig. 5c, Supplementary Fig. 7b).
For example, 2 mM combination of each NO and H2S yields
a peak HNO concentration of ca. 0.5 mM, similar to effects
of almost three orders of magnitude higher AS concentration
(1mM, Fig. 5c).
Finally, HNO formation was also tested on cellular level using a
HNO-selective ﬂuorescent sensor30. Only the combination of
applied NO and H2S provided strong ﬂuorescence signals
characteristic of HNO (Fig. 5d). Interestingly, a basal
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ﬂuorescence of the untreated cultured neurons was observed,
suggesting that some basal formation of HNO was constitutively
present. Thus, we inhibited enzymatic NO and/or H2S production
to see the effect on basal intracellular HNO level. In neurons,
treatment for 2 h with either L-NMMA (inhibitor of NOS),
oxamic acid (inhibitor of cystathionine beta synthase, CBS) or
with the combination of both resulted in a dramatic decrease of
the basal intracellular HNO signal (Supplementary Fig. 7c). DRG
cells deprived of arginine, cysteine or both for 2 h (Fig. 5e)
provided the same results, suggesting that the majority of
intracellularly produced HNO originated from the interaction
of NO and H2S that are constitutively produced.
Both NO and H2S are gasotransmitters and as such, could
freely diffuse into nerve ﬁbres31 to deliver paracrine signals. In
addition, upon adequate stimulation including Ca2þ inﬂux,
neurons may be able to produce HNO by themselves, modifying
TRPA1 to become more sensitive or activated in a sustained way.
Neuronal NOS has already been shown to colocalize with TRPA1
(ref. 32), but CBS has not been examined before. We thus focused
on detecting CBS and TRPA1 in sensory neurons and ﬁbres.
TRPA1 immunoreactivity was preferably found in small and CBS
in small and middle-sized trigeminal neurons, producing a yellow
colour in the merged image where both were colocalized (Fig. 5f).
High magniﬁcation shows the immune products in discrete,
well-organized structures conﬁrming a strong co-expression of
the H2S-producing enzyme with TRPA1. In confocal images of
cross-sections through the rat spinal trigeminal nucleus caudalis
(Supplementary Fig. 7d), bundles of immunostained afferent
nerve ﬁbres were seen running through the trigeminal tract and
into the superﬁcial laminae of the nucleus. Most of the nerve
ﬁbres show signals for both TRPA1 and CBS, producing the
yellow colour in the merged image.
HNO from NO and H2S activates TRPA1 to cause CGRP
release. While we show that NO provided by a pure NO donor
does not directly activate TRPA1 (Supplementary Fig. 2a), we also
tested H2S on cultured DRG neurons and could not see any
signiﬁcant change in intracellular Ca2þ levels when using
100–500 mM (Supplementary Fig. 8a). Prolonged exposures to
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H2S did, however, induce channel activation in a cysteine-
dependent manner (Supplementary Fig. 8b), but this treatment
inevitably leads to inhibition of cell respiration33 and transient
ROS formation34 both of which could activate TRPA1 (refs 35,36)
and cannot account for the physiological effects of H2S in low
concentration.
However, when combined, H2S and NO did induce dramatic
effects. The effects of combined H2S and NO (10–75 mM) were
scrutinized in the same way as previously for AS, using Ca2þ
imaging and patch clamp, TRPA1 agonists and antagonists,
knockouts and mutants and the outcomes were strikingly
identical to what was observed with HNO stimulation, a clear
speciﬁc activation of TRPA1 in sensory neurons through
interaction with the critical N-terminal cysteines (Fig. 6a–d and
Supplementary Fig. 9). Combination of 10 mM of each NO and
H2S induced a similar maximal response as that observed with
75 mM concentrations (Fig. 6a,c).
H2S has been suggested to modify cysteine residues inducing
formation of persulphides, however, a direct reaction of H2S with
cysteine residues is chemically impossible unless in the presence
of an oxidant37. Nonetheless, we used the puriﬁed N terminus of
TRPA1 channels (amino acids 1–719) and treated it with DEA
NONOate, H2S or both under hypoxic (2–5% O2) conditions to
minimize the artifactual oxidation of cysteine residues. Following
this, the protein was treated with IA to block all free cysteine
residues, then exposed to DTT to remove eventual cysteine
modiﬁcations and ﬁnally treated with Ellman’s reagent. If any
of the following modiﬁcations S-nitrosation, persulphide or
disulphide formation, were present it should have yielded a
yellow product formation with characteristic visible spectral
properties. However, only when the NO/H2S combination was
used such a characteristic product was observed, conﬁrming that
neither NO nor H2S directly modify the channel (Supplementary
Fig. 10a). Furthermore, a puriﬁed N terminus of TRPA1 mutant
hTRPA1-C621S/C641/C665S (amino acids 1–719) did not show a
positive Ellman’s reaction when exposed to the same treatments
(Supplementary Fig. 10b). Using the synthetic model peptide as in
Fig. 2, we conﬁrmed this ﬁnding (Fig. 6f; Supplementary Fig. 10c)
and could show that, when exposed to NO/H2S, the peptide gets
modiﬁed, because the m/z shift by 4 implies that two disulphide
bonds are formed as expected from our results with AS (Fig. 6f).
Finally, we puriﬁed the TRPA1 channel by immunoprecipitation
from dorsal root ganglia and compared the levels of endogenously
present disulphides, S-nitrosothiols and persulphides in controls
and ganglia treated with combination of NOS and CBS inhibitors.
Only endogenously present disulphides were found and their level
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was signiﬁcantly reduced by the treatment with L-NMMA and
oxamic acid, suggesting that HNO is a constitutive endogenous
regulator of TRPA1 activity (Fig. 6g).
Finally, we tested the ability of the NO/H2S combination to
induce CGRP release from the isolated mouse heart (Fig. 6h,
Supplementary Fig. 11a,b), because the heart is an important
target organ of circulating CGRP3,4. CGRP is released from
chemosensory primary afferent nerve ﬁbres located in the
epicardial surface of the heart, and human cardiomyocytes do
express the receptor for CGRP (Supplementary Fig. 11c,d). We
show that neither 250 nmol H2S nor NO have any signiﬁcant
effects on CGRP release. However, the combination of both
proved to be a robust stimulant with CGRP peaking at
38±4 pgml 1 in the efﬂuate (Fig. 6h). While HC030031
reduced this effect, the failure of the TRPV1 blocker BCTC, as
well as the use of TRPV1 / mice proved that TRPV1 is not
involved in this process (Supplementary Fig. 11b). If hearts from
TRPA1 / mice were used, the peak of the CGRP release was
reduced and the stimulant effect lasted much shorter compared
with congenic C57Bl/6 mice (Fig. 6h).
H2S vasodilatory effects are NO and TRPA1 and CGRP
dependent. To assess to what extent the H2S vasodilatory effects
are related to reduction of endogenous NO to HNO and
activation of the HNO–TRPA1–CGRP pathway, we ﬁrst
performed laser Doppler recordings of meningeal blood ﬂow in
the rat. Topical application of H2S induced a clear increase
in blood ﬂow (Fig. 7a,b). This effect was signiﬁcantly inhibited by
topical application of HC030031 as well as by intravenous (i.v.)
injection of the NOS inhibitor L-NMMA (Fig. 7a,b). Some H2S
response was retained even 90min after L-NMMA injection,
and this was completely inhibited by topical application of
glibenclamide (Fig. 7a,b), the KATP channel antagonist,
conﬁrming the additional role of KATP channel activation in
the action of H2S (refs 8,38).
I.v. injection of 0.9mg kg 1 Na2S led to an increase of blood ﬂow
in the rat medullary brainstem, which was followed by an increase
of CGRP levels in the cerebrospinal ﬂuid (Fig. 7c,d). CGRP release
was completely abolished in the presence of L-NAME and TRPA1
antagonists (Fig. 7c,d) conﬁrming that H2S has to react with NO to
stimulate the TRPA1–CGRP pathway.
To strengthen our hypothesis that the observed effects of H2S
could originate from the reaction with endogenous NO, we
applied H2S on cultured DRG neurons loaded with the speciﬁc
NO ﬂuorescent indicator DAF–FM–DA. Cells that were exposed
to 100 mM H2S showed lower intensity of ﬂuorescence, implying
that by H2S treatment NO is depleted from the cells
(Supplementary Fig. 11a). This effect was not restricted to DRG
neurons, but also evident in aorta rings, where the lower
ﬂuorescence intensity was again observed in H2S treated tissue
(Supplementary Fig. 11b).
In addition to local vasodilation, the effect of H2S on arterial
blood pressure was monitored. We ﬁrst assessed whether the
TRPA1–CGRP part of the pathway is important for the
regulation of systemic blood pressure. Application of HC030031
and CGRP8–37 led to a rise of blood pressure in rats, similar to
that observed with L-NAME application (Supplementary
Fig. 11c), suggesting that both CGRP release and TRPA1
activation play a constitutive role in the regulation of blood
pressure. I.v. injection of H2S caused a transient drop of blood
pressure by 45±1mmHg in wild-type mice, in a similar manner
and comparable amplitude as reported previously10. However,
signiﬁcant reductions of the H2S-induced blood pressure decrease
were observed in TRPA1 / mice (by 28mmHg) and
CGRP / mice (by 25mmHg), as well as in wild types
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receiving L-NMMA for 7 days through the drinking water (by
24mmHg, Fig. 8a).
If our hypotheses were valid, part of the NOS-generated NO
would react with H2S to give HNO and activate the TRPA1–
CGRP pathway. Inhibition of H2S production should thus affect
the MAP changes induced by NOS inhibitors. Indeed, the
administration of L-NMMA led to an increase of blood pressure
(12.5±1.2mmHg), but this change was signiﬁcantly inhibited by
pre-administration of H2S inhibitors (6.5±0.5mmHg) conﬁrm-
ing that part of the vasodilation induced by NOS activity is H2S
dependent (Supplementary Fig. 12c).
We further addressed the above question using the rat isolated
mesenteric artery, which is densely innervated with CGRP-
containing sensory nerve ﬁbres and potently relaxed by
exogenous CGRP as well as TRPA1 agonists20,39,40. The
treatment with H2S of mouse mesenteric vessels, in which
TRPA1 activators cause CGRP-mediated relaxation40, led to a
robust CGRP release, an effect that was completely abolished by
pretreatment with L-NMMA (Fig. 8b). Furthermore, using only
10 mM H2S, we induced almost complete relaxation of the
preconstricted rat blood vessels, an effect that was completely
reversed by subsequent addition of the CGRP receptor
antagonist (Fig. 8c). Pretreatment with the CGRP receptor
antagonist or the TRPA1 channel blocker inhibited the
vasodilatory effect of H2S, as did pretreatment with capsaicin,
which served to deplete the neurogenic pools of CGRP
(Fig. 8d,f,g). Most importantly, treatment with L-NMMA
completely blocked the relaxant effect of H2S (Fig. 8e).
L-NMMA treatment had no effect, however, on ring segments
of rat isolated thoracic aortas, which display a minor CGRP
innervation and negligible CGRP vasodilator responses39, and an
effect of H2S was observed only at toxic concentrations higher
than 1mM (not shown). This strongly suggests a systemic
relevance of the interaction between H2S and endogenous NO to
activate the HNO–TRPA1–CGRP pathway and thus contributes
to the control of vascular tone.
To add human translational evidence six adult volunteers
(three male, three female) received intradermal injections of DEA
NONOate, Na2S and the combination of both, in a double-
blinded study. NO induced a small, circumscribed vasodilation,
suggestive for a localized activation of the classical cGMP
pathway (Fig. 9a,b). H2S induced a minute and transient spot
of increased blood ﬂow, due to the very fast metabolic rate of its
removal41. However, when combined, these two gasotransmitters
induced a strong vasodilation with a large axon-reﬂex erythema
characteristic for the antidromic action potential propagation into
collaterals of wide-branching C-ﬁbres that release CGRP7,8
(Fig. 9a,b; Supplementary Fig. 12e). This was accompanied by
pain (Fig. 9c) and/or itch sensations (Fig. 9d) in all subjects. The
pain ratings were lower than observed with AS, but alternated
with itch sensations that were not previously reported with AS.
Discussion
In the past decade both chemical and physiological research on
nitroxyl (HNO) has shown that this congener of nitric oxide has
distinct ways of action3,4,6. Studies have reported that HNO may
be a co-product of NOS activity being converted back to NO by
Cu/Zn superoxide dismutase and other suitable electron
acceptors42,43. It has also been reported that the NOS
intermediate HO-Arg can be oxidized by catalase and hydrogen
peroxide or cytochrome P450 enzymes to produce HNO44
suggesting that HNO can not only be produced directly by
NOS but also from precursors such as HO-Arg. HNO operates
together with NO to mediate the classical EDRF-induced
dilatation in conduit arteries45–47 and also in mediating
nitrergic neurotransmission48. Still, the main pathways for
physiological generation of HNO and its way of action
remained elusive.
Here we provide translational evidence for a direct, HNO-
induced activation of neuronal TRPA1 channels, which is
followed by Ca2þ inﬂux and, consequently, by the release of
CGRP from ubiquitous, polymodal, sensory nerve ﬁbres and
endings. These effects are completely absent in mice lacking
TRPA1, blocked by a selective TRPA1 inhibitor, and not induced
by a pure NO donor, leading to the conclusion that the
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chemosensory TRPA1 channel is the prime target for
HNO-induced CGRP release and resulting cardiovascular effects.
Recent emergence of another gasotransmitter, H2S, raised the
possibility for its interaction with NO. Several groups have
considered that H2S effects could be linked to NO, including
the early studies that showed physiological effects of H2S (ref. 13).
In addition, positive inotropic effects of these combined
gasotransmitters on the heart have been demonstrated15,49,
which is one of the hallmarks of HNO physiology. However,
these studies mainly used sodium nitroprusside (SNP) as a source
of NO. Although it has ‘NO-like’ physiological effects, such as
cGMP-dependent vasodilation, SNP does not release NO unless
exposed to light50. We have recently published that the above
mentioned observations were in fact artefacts due to the fact that
SNP reacts with H2S directly to generate HNO and thiocyanates,
without the actual involvement of NO50.
Some of us were the ﬁrst to identify that H2S could be involved
in TRPA1 receptor activation19 with several follow-up studies
suggesting the same51,52. Furthermore, previous studies have also
linked H2S to TRPA1 and microvascular blood ﬂow mediated by
CGRP53 and H2S and TRPA1/TRPV1 intestinal pro-secretory
actions54. However, only very high concentrations of H2S
activated TRPA1 (as we also observed, Supplementary Fig. 10).
These effects are, however, most likely outside the physiological
concentration range and should stand for inhibition of cell
respiration33 and/or generation of ROS34 both of which can
induce TRPA1 activation35,36. In addition, polysulphides,
inevitable contaminants of NaHS solutions used in these
studies19,51,52, could be the reason for the activation of the
TRPA1, as shown recently55. H2S, just like NO, cannot react
directly with thiols due to thermodynamic constraints37.
Using selective methods for in vitro and intracellular HNO
detection, our data suggest that the gasotransmitter H2S may
transform endogenous NO to HNO, which activates the HNO–
TRPA1–CGRP cascade, suggesting broad physiological relevance
of the ﬁndings. Mechanistic details of direct reaction between
NO and H2S will be subject of further studies. As we previously
demonstrated, it is plausible that H2S-mediated generation of
HNO in vivo could be additionally related to its reaction with
S-nitrosothiols16, as well as with metal nitrosyls56.
Data supporting the notion that H2S may react with NO to give
HNO, and our demonstration that H2S effects could be
diminished by either blocking NOS activity or deleting TRPA1
or CGRP are in favour of a new signalling pathway for
cardiovascular control. In addition, co-expression of TRPA1
and CBS in small to medium-sized sensory neurons and
axons together with the recent demonstration of co-expression
of TRPA1 and nNOS32 suggest a structural and functional
organization for constitutive HNO generation and subsequent
activation of TRPA1-dependent CGRP release. This functional
unit is of importance in the regulation of peripheral blood ﬂow
(as demonstrated in dura mater and brainstem) and even of
systemic blood pressure. In addition, positive inotropic and
lusitropic cardiac effects of circulating and/or paracrine CGRP
have been reported3,4,7. The positive inotropic and lusitropic
effects of HNO were originally ascribed to CGPR release and
completely blocked by the use of CGRP receptor antagonist,
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Figure 9 | Combination of NO and H2S induces axon-reﬂex erythema in
humans. (a) Laser Doppler scanned pseudocolor images of volar forearm of
human volunteers (3 male, 3 female) after intracutaneous injection of DEA
NONOate (0.23mmol), Na2S (0.35mmol) or both. (b) Flare size after
intracutaneous injection of Na2S, DEA NONOate or combination of both.
When H2S and NO were intracutaneously injected to the volar forearm of
human volunteers, blood ﬂow increased locally following DEA NONOate
(0.23 mmol), while H2S (0.35mmol) hardly evoked any response apart from
slight irritation due to the injection needle. Injection of H2S and NO in
combination however led to widespread vasodilatation in agreement with
formation of an axon-reﬂex erythema due to activation of nerve ﬁbers,
antidromically propagated action potentials and concomitant CGRP release
(repeated measures analysis of variance (ANOVA) honestly signiﬁcant
difference (HSD) post hoc tests; #Po0.01 H2S and NO versus H2S; *Po0.01
H2S and NO versus H2S and NO; n¼ 6; all error bars represent s.e.m.).
(c) Pain and (d) itch ratings from the experiments shown in a (repeated
measures ANOVA HSD post hoc tests; #Po0.01 H2S and NO versus H2S;
*Po0.01 H2S and NO versus H2S and NO; n¼6; all error bars represent
s.e.m.).
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CGRP8–37 (ref. 4). Expression of CRLR in cardiomyocytes was
previously documented for the rat heart57 and we conﬁrmed its
presence at the protein level in human hearts (both, the
membranous and cytoplasmic distribution) using indirect
immunoﬂuorescence. These results explain the CGRP receptor-
mediated positive inotropic effects that have previously been
reported from isolated trabecular muscles of the human heart58.
Also on rat cardiomyocytes, direct CGRP-mediated inotropic and
lusitropic effects have recently been demonstrated59. Thus, the
failing heart may gain particular beneﬁt from CGRP release, as
coronary blood ﬂow is increased and afterload (peripheral
resistance) reduced by CGRP60. Thereby, it would not really
matter whether beneﬁcial effects derive from circulating plasma
levels of CGRP or from paracrine release from ubiquitous sensory
nerves that accompany every peripheral blood vessel.
All three, NO, H2S and HNO are freely diffusible, so several
possibilities could be envisioned for TRPA1 activation and CGRP
release (Fig. 10): (i) NO and H2S produced in endothelium react
to give HNO that could diffuse and activate nearby nerve endings
expressing TRPA1 and releasing CGRP that relaxes vascular
smooth muscles; (ii) production of H2S and NO from colocalized
CBS and neuronal NOS leads to intracellular HNO formation and
TRPA1 activation; (iii) taking into account that constitutive levels
of NO in neurons are very low61 it is also plausible that, for
instance in the CNS, astrocyte-derived NO, as a paracrine signal,
meets with endothelial or neuronal H2S, forming HNO, which
activates TRPA1 in primary afferent peptidergic terminals. Recent
work showed that the NO vasodilatory effect on aorta rings is
partially blocked by inhibiting H2S production, vice versa H2S
effects are diminished by inhibiting NO production, further
strengthening the link between these gasotransmitters14. Our data
on isolated blood vessels suggest that most of H2S-induced
vasodilation is directly dependent on its reaction with NO to form
HNO, as well as on functional presence of TRPA1 and CGRP.
Formation of disulphides as a mode of channel activation, as
shown in this study, may have a broader impact on under-
standing the multiple mechanisms for TRPA1 activation, as other
activators could use the same mechanism. We22 and others62
have recently demonstrated the formation of disulphides in the N
terminus of TRPA1 by other endogenous (methylglyoxal) and
exogenous (N-methylmaleimide) activators. Although the initial
reaction with C621, C641 and/or C665 is unquestionable, the
extent to which neighbouring cysteines interact, as well as the
extent to which the size, hydrophilicity and charge of the activator
could determine the half-life of the disulphide-induced
conformational change, remain to be elucidated in further
studies. In case of HNO, the activation is particularly long
lasting and could be reversed by a reducing agent. Thus, if
reducing equivalents are scarce, as in conditions of oxidative
stress, and/or when H2S and NO are produced in excess,
pathophysiological effects of the HNO–TRPA1–CGRP (plus
substance P) pathway are well conceivable. Being a nociceptive
transduction channel in the ﬁrst place, TRPA1 contributes to
pain/itch sensations and possibly excessive CGRP release into the
jugular venous blood63, for example, where also plenty of
metabolic NO products are found during migraine attacks64.
The deciphering of the HNO–TRPA1–CGRP pathway pro-
vides several new targets for future drug design. A century after
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the demonstration that the classical TRPA1 agonist mustard oil
acts as a strong vasodilator65, the ion channel responsible for this
action could be considered as a co-mediator of endogenous ligand
effects that lower the blood pressure and strengthen the heart66,67
both effects of CGRP that would be highly appreciated in the
treatment of cardiac failure.
Methods
Chemicals. Stock solutions of DEA NONOate and AS were prepared in 10mM
KOH and diluted with physiological buffer (pH 7.4) immediately before use to
minimize the loss of activity due to spontaneous decomposition of these salts at
neutral pH. 300mM phosphate buffer (KPi) was prepared with nanopure water,
stirred with Chelex-100 resins to remove traces of heavy metals (and when
appropriate supplemented with 100mM neocuproine) and kept above the resins
until used. Sodium sulphide (Na2S) was purchased as anhydrous, opened and
stored in a glove box (o1 p.p.m. O2 and o1 p.p.m. H2O). 100mM and 10mM
stock solutions of sodium sulphide were prepared in the glove box using argon-
bubbled nanopure water and stored in glass vials with PTFE septa at þ 4 C, for a
maximum of one week. The concentration of H2S was determined using a H2S
selective electrode (World Precision Instruments, USA). Gas-tight Hamilton
syringes were used for handling Na2S solution.
Cell culture. DRGs of C57Bl/6 or TRPA1 / mice were excised and transferred
into Dulbecco’s modiﬁed Eagle’s medium containing 50 mgml 1 gentamicin.
Following treatment with 1mgml 1 collagenase and 0.1mgml 1 protease for
30min ganglia were dissociated by trituration with a ﬁre-polished silicone-coated
Pasteur pipette. For plating, coverslips were coated with poly-D-lysine
(200 mgml 1, Sigma-Aldrich, Germany) and cells were cultured in TNB 100 cell
culture medium supplemented with TNB 100 lipid–protein complex, 100 mgml 1
streptomycin and penicillin (all from Biochrom, Berlin, Germany) and mouse
NGF (100 ngml 1, Alomone Labs, Tel Aviv, Israel) at 37C and 5% CO2. All
experiments were performed within 24 h of dissociation.
HEK 293t cells were transfected with plasmids of hTRPV1, hTRPA1, mTRPA1
or mutant hTRPA1 (1mg each) using Nanofectin (PAA, Pasching, Austria).
Twenty-four hours after transfection cells were plated on coated coverslips and
used for calcium imaging experiments the same day. Human and mouse TRPA1
cDNA and cDNA of a mutant hTRPA1 lacking lysine and/or cysteine residues in
the intracellular domain (C621S, C641S, C665S þ / K710R) were a kind gift
from Dr Sven-Eric Jordt (Department of Pharmacology, Yale University, New
Haven, USA).
Chinese hamster ovary cells expressing mTRPA1 were a gift from Dr Ardem
Patapoutian (The Scripps Research Institute, La Jolla, USA).
Animals. TRPA1 knockout mice were a gift from Drs. David Corey and Kelvin
Kwan (Harvard University, Boston, USA); TRPV1þ / came from Dr John Davis
(formerly GSK, Harlow, UK) and CGRP (Calca)þ / from Dr Jean-Pierre Chan-
geux (Institut Pasteur, Paris, France). For measuring CGRP release and culturing
neurons of dorsal root ganglia (DRG), mice and rats were suffocated in rising CO2
atmosphere. For in vitro studies, animals of both sexes were used. Rats weighed up
to 400 g and mice up to 28 g. Euthanasia as well as in vivo studies on isoﬂurane
anaesthetized mice and rats were performed in accordance with ethical principles
for animal care and treatment of the International Association for the Study of
Pain. All experimental procedures were carried out in compliance with the
guidelines for the welfare of experimental animals stipulated by the Federal
Republic of Germany and approved by the animal protection authorities of the
Friedrich-Alexander University Erlangen-Nuremberg and the local district gov-
ernment (reference number 54-2532.1-21/12). TRPA1 and CGRP knockout mice
were backcrossed over more than nine generations to C57Bl/6J background and
constantly genotyped.
Human tissue samples. The retrospective examination of pseudonymized human
(cardiac) tissue samples (from archival tissues or obtained from autopsies with
permission by relatives and institutional approval for collection of research
biomaterials), was performed in compliance with university ethics committee
guidelines and the German federal law for correct usage of archival tissue for
clinical research (Reference Dtsch. Arzteblatt 2003:100: A1632).
Statistics. Comparison of two groups was performed by the respective t-test and
with a non-parametric test for no10. More than two groups were compared by
analysis of variance following least signiﬁcant difference or honestly signiﬁcant
difference post hoc tests as stated using Statistica 7 software (StatSoft, Tulsa, USA).
Differences were considered signiﬁcant at *Po0.05.
HNO ﬂuorescent imaging. For nitroxyl ﬂuorescent imaging, DRG neurons were
plated in poly-D-lysine coated 35mm high m-dishes ibiTreat (Ibidi, Germany). Cells
were incubated with 10 mM CuBOT1 in Hank’s buffer for 20min. After washout,
cells were treated with AS, DEA NONOate, Na2S (100 mM each) or medium as a
control for 15min. In addition, cells were preincubated with 1mM L-NMMA,
1mM oxamic acid or combination of both for 2 h or kept in medium without
arginine, cysteine or without both for partial depletion of NO and/or H2S, before
staining with CuBOT1, to quantify the effects on basal HNO production. Fluor-
escence microscopy was carried out using Carl Zeiss Axiovert 40 CLF inverted
microscope, equipped with green ﬂuorescent ﬁlters and AxioCam ICm1. Images
were post processed in ImageJ software68 where semi-quantitative ﬂuorescence
intensity was determined.
Intracellular detection of NO with DAF-FM. For the intracellular detection
of NO, cells (cultured DRG neurons) were incubated with 5 mM 4-amino-5-
methylamino-20,70-diﬂuorescein diacetate (DAF–FM–DA) for 30min in the
absence or presence of 100 mM sodium sulphide. The cells were washed three times
and placed in external solution (as used for calcium imaging experiments, see
below). The dye was excited with 488 nm laser line on LSM 780 confocal laser
scanning system (Carl Zeiss MicroImaging, Jena, Germany) equipped with an
Argon laser mounted on an inverted Axio Observer Z1. All experiments were
performed in triplicate. Images were processed in ImageJ software where
semi-quantitative ﬂuorescence intensity was determined.
Analysis of NO and H2S. Two microlitres of 50mM KPi buffer pH 7.4 was added
into the chamber and the electrodes were immersed into it. Depending on the type
of measurement, different concentrations of Na2S solution were injected followed
by the addition of either NO or DEA NONOate solutions. The studies were also
performed with NO or DEA NONOate being injected ﬁrst and then followed by
injection of H2S. The fate of H2S and NO during the course of the reaction was
monitored by a Free Radical Analyzer (WPI, USA) connected to a computer
equipped with DataTrax software for the signal processing. Experiments were
performed in a four-channel chamber (WPI) with both electrodes at the same time
or each of them separately. When needed the solutions were degassed with argon
and kept closed in measuring chamber securing anaerobic conditions, which were
constantly monitored by additional oxygen electrode.
Amperometric detection of HNO. Measurements of HNO concentration were
carried out with our previously described method based on a three-electrode
system consisting of platinum counter electrode, Ag/AgCl reference electrode and a
gold working electrode modiﬁed with a monolayer of cobalt porphyrin with
1-decanethiol covalently attached. The method has been demonstrated to be
speciﬁc for HNO, showing no interference or spurious signal due to the presence of
NO, O2, NO2 and other RNOS29 Signal recording was performed with a TEQ 03
potentiostat. For each case, we also conﬁrmed that the maximal concentrations
(2mM) of NO, H2S and cysteine produced very small signals that can be
disregarded.
High-resolution ESI–TOF–MS. Being previously degassed with argon for 5min,
20 mM model peptide was exposed to 1mM H2S, 1mM DEA NONOate or the
combination of both. The samples were analysed on maXis, a high-resolution
ESI–TOF mass spectrometer (Bruker, Bremen, Germany). The samples were
injected using a syringe pump at a ﬂow rate of 240 ml h 1. Nitrogen was used as the
nebulizing gas at a pressure of 10 psi and as the drying gas at a temperature of
180 C and a ﬂow rate of 5 min 1. All experiments were carried out in the positive
ion mode and obtained spectra deconvoluted and further processed in Data
Analysis software provided by Bruker Daltonics. Analytical samples were prepared
by mixing peptide samples in water with a mixture of 0.1% formic acid in
water/acetonitrile (1:1, v/v).
TRPA1 puriﬁcation. For puriﬁcation of mTRPA1 protein mTRPA1, DNA was
cloned into a pcDNA3.1/V5–His-TOPO vector (Invitrogen, Life Technologies,
Darmstadt, Germany). hTRPA1 as well as hTRPA1-C621S/C641S/C665S were
cloned into the same vector and truncated to the N-terminal segment hTRPA1-1–
719-V5–His. HEK 293t cells were transfected with the plasmid using Nanofectin
(PAA, Pasching, Austria) and cultured for 2.5 days in 175 cm2 ﬂasks before
collection and puriﬁcation of V5–His tagged mTRPA1 protein. The tag did not
seem to inﬂuence function of TRPA1 as in Ca2þ imaging activation by AS and
carvacrol showed comparable results to the untagged receptor channel. V5–His
tagged mTRPA1-expressing HEK cells were collected in TNE buffer (0.15M NaCl,
20mM Tris–HCl, 1mM EDTA pH 7.4) supplemented with 1% NP-40 and 10%
proteinase inhibitor cocktail (Sigma-Aldrich) and lysed by trituration with a
syringe and 26G needle. The cell extract was placed on a rotator (6 r.p.m.) at 4C
for 30min and centrifuged. The supernatant was puriﬁed by immobilized metal
afﬁnity chromatography on a column with nickel beads following the instructions
of the manufacturer (Sigma-Aldrich). The presence of TRPA1 was conﬁrmed with
anti-V5 antibodies (mouse monoclonal IgG2a, R961-25 Invitrogen).
Modiﬁed biotin-switch assay for disulphide bond detection. For disulphide
bond detection, puriﬁed mTRPA1 channel (50 mM) was ﬁrst treated with 1mM
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DTT and subsequently puriﬁed using Micro Bio-Spin Columns with Bio-Gel P-6
(Bio-Rad). The protein was then exposed to either 500mM or 1.5mM AS for
15min, while a sample that was ﬁrst modiﬁed with IA to block all the available SH
groups before application of 1.5mM AS was used as negative control. The samples
were desalted on Micro Bio-Spin Columns with Bio-Gel P-6 (Bio-Rad) and pro-
cessed as follows: (i) 5mM IA (45min at 37 C), (ii) 1mM DTT (1 h at 37 C) and
(iii) 5mM biotin-maleimide (45min at 37 C). The presence of biotinylated
proteins was conﬁrmed with mouse monoclonal anti-biotin peroxidase-labelled
antibodies (Clone BN-34, A0184, Sigma-Aldrich).
MALDI-TOF characterization of AS-induced modiﬁcation of hTRPA1. A model
peptide of the intracellular N-terminal part of hTRPA1 including amino acids
607-670 (UniProt database, O75762, Thermo Fischer Scientiﬁc) was used to
evaluate AS effects on cysteines. A quantity of 50 mM peptide in 20mM ammonium
bicarbonate buffer pH 7.4 was treated with 500 mM Angeli’s salt for 15min and
then incubated with 1mM IA for 45min. Hydrophobic MALDI-TOF plate was
pre-crystallized with sinapinic acid matrix, a supersaturated solution of 4-hydroxy-
3,5-dimethoxycinnamic acid in acetonitrile, 0.1% TFA (50:50, v/v). Samples were
mixed with sinapinic acid in a 1:3 ratio and spotted onto the plate.
Ab initio peptide structure prediction. A model structure of the peptide con-
taining critical cysteine residues was obtained by ab initio protein folding and
protein structure prediction using QUARK software69.
Detection of disulphides, S-nitrosothiols and persulphides. DRGs were pre-
pared as described above. In addition, cells were treated with 2mM combination of
oxamic acid and L-NMMA for 12 h. After that cells were lysed in TNE buffer
(0.15M NaCl, 20mM Tris–HCl, 1mM EDTA pH 7.4) supplemented with 1% NP-
40, 10% proteinase inhibitor cocktail (Sigma-Aldrich) and 50mM MSBT-A37 using
ultrasonicator. TRPA1 was immunoprecipitated with anti-TRPA1 antibodies
(rabbit polyclonal IgG, ab58844, Abcam) and the samples split on three to be
analysed for: (i) disulphide formation by reducing the proteins with DTT,
removing DTT on Micro Bio-Spin Columns with Bio-Gel P-6 (Bio-Rad) and
labelling with biotin-maleimide; (ii) S-nitrosothiol content, by treating the extracts
with 1mM ascorbate, 5 mM copper sulphate and biotin-maleimide; and (iii)
persulphide formation, by treating the cells with CN-biotin37. The presence of
biotinylated proteins was conﬁrmed with mouse monoclonal anti-biotin
peroxidase-labelled antibodies (Clone BN-34, A0184, Sigma-Aldrich).
Patch clamp. Membrane currents were acquired with an EPC10 USB HEKA
ampliﬁer (HEKA Elektronik, Lamprecht, Germany), low passed at 1 kHz, and
sampled at 2 kHz. Electrodes were pulled from borosilicate glass tubes (TW150F-3;
World Precision Instruments, Berlin, Germany) and heat polished to give a
resistance of 3–5Mo. The standard external solution contained (in mM) NaCl 140,
KCl 5, MgCl2 2, EGTA 5, HEPES 10 and glucose 10 (pH 7.4 was adjusted with
tetramethylammonium hydroxide). The internal solution contained (in mM) KCl
140, MgCl2 2, EGTA 5 and HEPES 10 (pH 7.4 was adjusted with KOH). If not
otherwise noted, cells were held at  60mV. For IV curves with and without
Angeli’s salt, currents were measured during 500ms long voltage ramps from
 100 to þ 100mV. All experiments were performed at room temperature.
Solutions were applied with a gravity-driven PTFE/glass multi-barrel perfusion
system. The PatchMaster/FitMaster software (HEKA Elektronik) was used for
acquisition and off-line analysis.
Ratiometric [Ca2þ ]i measurements. Cells were stained by 3 mM fura-2-AM and
0.02% pluronic (both from Invitrogen) for about 30min. Coverslips were mounted
on an Olympus IX71 inverse microscope with a  10 objective and constantly
superfused with extracellular solution (in mM: NaCl 145, KCl 5, CaCl2 1.25, MgCl2
1,Glucose 10, HEPES 10) using a software controlled 7-channel gravity-driven
common-outlet superfusion system. Fura-2 was excited at 340 and 380 nm by a
Polychrome V monochromator. Images were exposed for 200 ms and acquired at a
rate of 1Hz with a 12–bit CCD camera (Imago Sensicam QE). Data were recorded
and further analysed using TILLvisION 4.0.1.3 software (all from Till Photonics,
Munich, Germany). Background ﬂuorescence was subtracted before calculation of
ratios. A 60mM potassium (DRG neurons) or 10 mM ionomycin stimulus (HEK
cells) was applied as a control at the end of each experiment. Averaged results are
reported as means (±s.e.m.) of area under the curve (DF340 nm/F380 nm) for
regions of interest adapted to the neurons.
Recording of vasorelaxation. Arterial ring segments of the ﬁrst and second-order
branches of male Wistar–Hannover rats (250 g) mesenteric artery were carefully
dissected and suspended between two stainless steel wires in temperature-
controlled tissue baths (37 C), containing aerated (20% O2 and 5% CO2 in N2)
physiological salt solution (composition in mM: NaCl 119, KCl 4.6, CaCl2 1.5,
MgCl2 1.2, NaHCO3 15, NaH2PO4 1.2 and D-glucose 6; pH 7.4), under a passive
load of 1mNmm 1 vessel length. One of the wires was connected to a force-
displacement transducer model FT03 C (Grass Instruments; Rhode Island, USA)
for isometric tension recording. The vessel segments were initially exposed to 10 7
to 10 5 M phenylephrine to estimate the maximal contractile capacity.
Vasorelaxation was studied in arterial segments submaximally contracted with
phenylephrine; the phenylephrine concentration was titrated in each experiment to
obtain a stable contraction amounting to B80 % of the maximal response.
Vasorelaxation of phenylephrine (3mM)-preconstricted ring segments of rat
second-order mesenteric artery branches (n¼ 4–6) was induced by 10mM Na2S,
without or with pretreatment for 30min with 1mM L-NMMA, 10 mM capsaicin,
3 mM CGRP8–37 and 100 mMHC030031 before the constriction. Capsaicin (10 mM),
and the smooth muscle relaxants CGRP (10 nM) and KATP opener levcromakalim
(LC, 1 mM) were added at the end to exclude nonspeciﬁc inhibition of the sensory
nerve-mediated vasodilator pathway. Vasorelaxation was expressed as percentage
reversal of the phenylephrine-induced contraction.
Stimulated CGRP release. Stimulated CGRP release from dura of mice and rats
and desheathed sciatic nerves of mice, as well as mouse heart and cerebrospinal
ﬂuid was studied27. Hemisected skull halves served as incubation chambers to
expose the arachnoidal side of the dura to carbogen-gassed synthetic interstitial
ﬂuid (SIF), (consisting in (mM) 108 NaCl, 3.48 KCl, 3.5 MgSO4, 26 NaHCO3, 1.7
NaH2PO4, 1.5 CaCl2, 9.6 sodium gluconate, 5.5 glucose, 7.6 sucrose, pH 7.4 with or
without compounds added for stimulation of CGRP release. Similarly, sciatic
nerves and mesenteries were tied and passed through a series of incubations based
on SIF each lasting for 5min at 37 C, while CGRP release was stimulated in the
third to ﬁfth incubation period. Samples were immediately stored on ice and CGRP
was measured by a commercial enzyme immune assay (Bertin Pharma, Montigny,
France). For studying CGRP release from isolated C57BL/6 mice were suffocated in
raising CO2 atmosphere and the complete heart was excised by cutting the central
blood vessels. The hearts were passed through a series of SIF incubations with or
without test compounds added, spending 5min in each test tube at 37 C (for
details see Supplementary Fig. 11a). Essentially the same procedures were applied
to the C57BL/6 mouse mesentery of the small intestine that was isolated in one
piece, measuring baseline CGRP neurosecretion and its changes upon H2S
stimulation. If L-NMMA was employed to suppress NO synthesis, the compound
was added during the equilibration period of the excised tissues and present during
most of the experimental phase.
Meningeal and medullary brainstem blood ﬂow. Adult male Wistar rats
weighing 300–400 g were anaesthetized with isoﬂurane. The animals were tra-
cheotomized and artiﬁcially ventilated with oxygen-enriched room air and 2%
isoﬂurane. The frequency of the ventilation was adjusted to maintain the end-
expiratory CO2 at 3.5% to suppress spontaneous breathing. Systemic blood pres-
sure was recorded with a pressure transducer connected to a catheter inserted into
the right femoral artery. A catheter inserted into the right femoral vein served for
systemic administration of drugs. The body temperature of the animals was
monitored with a thermoprobe inserted into the rectum and was held at 37–37.5 C
with a feedback-controlled heating pad.
For measurements of meningeal and medullary brainstem blood ﬂow, the head
of the animal was ﬁxed in a stereotaxic frame and the parietal bone was exposed on
one side. A cranial window was drilled into the parietal bone to expose the cranial
dura mater. The neck muscles were separated in the midline and the underlying
atlanto-occipital ligament and spinal dura mater were opened to expose the
medullary brainstem. Meningeal and medullary blood ﬂow were measured with
needle-type probes (tip diameter 0.8mm) of a laser Doppler ﬂowmeter (Moor
Instruments, DRT4) positioned over a branch of the middle meningeal artery and
on the medullary brainstem.
Blood ﬂow was recorded at a sampling rate of 1Hz and expressed in arbitrary
perfusion units. Meningeal blood ﬂow, systemic blood pressure and body
temperature were recorded simultaneously and stored on a computer using
MoorSoft software for Windows. The mean blood ﬂow measured during a 3-min
period before drug application was regarded as the basal ﬂow. Changes induced in
blood ﬂow by the application of drugs were expressed as percentage of changes
relative to the basal ﬂow (mean±s.e.m.) calculated for the 5-min application
period or separately for each minute of application. At the end of the experiments,
the animals were killed with an overdose of i.v. thiopentone.
For analysis of corresponding liquor CGRP levels, the cerebrospinal ﬂuid
covering the exposed dorsal surface of the medullary brainstem was collected with
a micropipette without touching the medulla. A quantity of 25 ml of sample was
taken following i.v. injection of Na2S (70.2 mg kg 1) with or without blockers of the
proposed signalling cascade when brainstem blood ﬂow measurements were
ﬁnished. All samples were immediately transferred to Eppendorf cups and diluted
with EIA buffer at a volume of four times the volume of cerebrospinal ﬂuid and
then they were stored at  20 C for later analysis by enzyme-linked immunoassay
(Bertin Pharma). The CGRP concentration was calculated in pgml 1,
compensating the added volume of EIA buffer.
Assessment of systemic blood pressure in mice. Male mice (weighing up to
25 g) were anaesthetized with isoﬂurane supplied with a mask and the right carotid
arteries were catheterized to measure intraarterial blood pressure via a transducer
connected to a polygraph (Hellige, Freiburg, Germany) while the substances were
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injected through the catheterized left jugular vein. AS was injected at a dose of
61mg kg 1 freshly dissolved in saline pH 7.0, which also served as a control. In
addition, anaesthetized C57Bl/6, TRPA1 / and CGRP / mice were injected
with 39 mmol kg 1 Na2S. One group of C57Bl/6 mice was also treated with
10mg l 1 of L-NMMA in drinking water ad lib for 7 days prior the injection of
Na2S. C57Bl/6 mice were also treated with 6 mg g 1 of oxamic acid and pro-
pargylglycine each, and after 10min 6 mg g 1 of L-NMMA was injected. The
reverse experiment was performed with ﬁrst injecting the L-NMMA, and then the
combination of OXA and PG. At the end of experiments, animals were killed by
cervical dislocation in deep anaesthesia.
Psychophysics. Studies on human volunteers were limited to some authors of
the present study and experimental procedures were approved to fulﬁl the
requirements of the Declaration of Helsinki by the ethics committee of the
Friedrich-Alexander University of Erlangen-Nuremberg. AS (10 nmol kg 1), DEA
NONOate (3.33 nmol kg 1) and decomposed AS as a control or in a second study
DEA NONOate (3.33 nmol kg 1), Na2S (5 nmol kg 1) or a combination of both
were intradermally injected in 70 ml volume to the volar forearm of the volunteer
(n¼ 6 each; 3 male and 3 female) in a double-blinded manner. Pain and itch were
assessed on a numerical rating scale (NRS), ranging from 0 (no sensation) to 10
(maximum pain/itch imaginable) in 15 s intervals for a period of 10min.
Numerical ratings (0–10) to a 5 s lasting heat stimulus of 47 C were compared
before and after application of substances and the skin was tested for dynamic
mechanical allodynia by applying gentle pressure with a cotton swab and stroking
with a ﬁne brush. A laser Doppler imager (LDI, Moore, London, UK) was used for
recording changes in superﬁcial blood ﬂow. Two baseline scans of 0.5mm spatial
resolution were taken, following scans every 2.5min starting right after the injec-
tions and a ﬁnal one after 20min. Area of superﬁcial vasodilation was analysed
with MLDI 3.0 software (Moore) and deﬁned as pixels in which intensity exceeded
the mean of basal values plus two standard deviations.
Immunohistochemistry of aortas. For immunohistochemistry of aortas Wistar
rats suffocated in rising CO2 atmosphere were immediately thoracotomized and
the aorta from the ascending part to the abdominal part was dissected and placed
in cold SIF (see above). Rest of the peritoneum was removed. At different levels,
cross-sections of about 0.1mm were cut with a sharp scalpel to produce aorta rings.
For NO detection, aorta rings were preloaded with 25 mM DAF-FM for 60min.
Fluorescence microscopy was carried out using an inverted microscope (Axiovert
40 CLF, Carl Zeiss) with magniﬁcation  20, equipped with green ﬂuorescent
ﬁlters and AxioCam ICm1. Images were processed using ImageJ software.
Immunohistochemistry of trigeminal ganglia and brainstem. Adult Wistar rats
were deeply anaesthetized by inhaling 4 % isoﬂurane and intraperitoneal injection
of 0.5ml Trapanal (thiopental, Nycomed, Konstanz, Germany). After quick
thoracotomy, warm isotonic saline was perfused through the left ventricle for about
3min followed by a solution of 4% paraformaldehyde in phosphate-buffered saline
(PBS) for about 5min. After opening of the occipital scull and cervical lami-
nectomy, the brainstem was quickly dissected. Trigeminal ganglia were carefully
excised from the skull base. Brainstem and trigeminal ganglia were placed in the
ﬁxation solution for about 1 h, washed in PBS, mounted on Tissue-Tek (Slee,
Mainz, Germany), rapidly frozen in liquid nitrogen and stored in the freezer at
 20C. The ganglia were cut into series of 14 mm longitudinal sections using a
cryostat (Leica, Bensheim, Germany). Sections were mounted on poly-L-lysine-
coated slides (Sigma-Aldrich, Steinheim, Germany) and dried for 1 h at room
temperature before immunostaining. After rinsing in PBS (0.01M, pH 7.4), the
mounted sections were preincubated for 1 h at room temperature with a solution of
5% goat serum (Dianova, Hamburg, Germany) in PBS with 0.5% Triton X-100 and
1% bovine serum albumin. Sections were rinsed in PBS for another 5min and
incubated with two primary antibodies raised in rabbit directed against TRPA1
(Abcam, ab58844; 1:100) and in mouse directed against cystathionine beta synthase
(Santa Cruz, sc-133154, 1:100) at room temperature overnight. Sections were
washed with PBS three times for 5min and incubated with ﬂuorescent secondary
antibodies for 1 h at room temperature: goat anti-rabbit IgG coupled to indo-
carbocyanine (Cy3, Dianova 111-165-144; 1:133) and anti-mouse IgG coupled to
FITC (Sigma-Aldrich, St Louis, MO, 1:500) (40 ,6-diamidino-2-phenylindole
hydrochloride; Sigma-Aldrich, St Louis) for labelling of nuclear DNA was added at
a concentration of 2 mgml 1 to the secondary antibody. Sections were rinsed again
three times for 5min with PBS, coverslipped in Fluoromount G (Southern Biotech,
Birmingham, AL), and stored at 4C in the dark. To verify the speciﬁcity of the
immunohistochemical reactions, stainings were controlled by omitting primary
antibodies, which resulted in no immunoﬂuorescence. Sections were examined and
images of 1024 1024 pixels were obtained using a LSM 780 confocal laser
scanning system (Carl Zeiss MicroImaging) equipped with an Argon laser (458,
488, 514 nm), a diode laser (405 nm), a DPSS-laser (561 nm) (LASOS Lasertechnik,
Jena, Germany), mounted on an inverted Axio Observer Z1. The ﬁlter settings
of the confocal scanner were: 514 nm excitation for Cy3 (MBS 458/561, ﬁlter
566–681 nm), 488 nm excitation for Alexa 488 (MBS 488/561/633), ﬁlter
493–543 nm) and 405 nm excitation for 40 ,6-diamidino-2-phenylindole hydro-
chloride (MBS-405). A  20 dry objective lens (numerical aperture 0.8) and a  63
oil objective lens (numerical aperture 1.4) were used. Sequential scanning and
appropriate pinhole settings minimized spectral bleed-through. For examination of
colocalization of immunoﬂuorescence, single optical sections at the same focus
plane were taken separately and the three corresponding channels were merged
into a 8-bit RGB tiff-ﬁle using confocal assistant software ZEN 2010.
Immonohistochemistry of human heart tissue. The retrospective examination of
pseudonymized human (cardiac) tissue samples (from archival tissues or obtained
from autopsies with permission by relatives and institutional approval for
collection of research biomaterials), was performed in compliance with
Universita¨tsklinikum Ulm ethics committee guidelines and the German federal law
for correct usage of archival tissue for clinical research (Reference Dtsch. Arzteblatt
2003:100: A1632). For immunoﬂuorescence staining parafﬁn-embedded tissue was
washed for 5min three times with xylene, twice with 100% EtOH, once with 95%
EtOH, once with 70% EtOH and once with PBS. Sections were boiled in Tris pH6.0
for antigen retrieval, rinsed in deionized water for 15min and washed with PBS.
Sections were blocked in 1% BSA, 0.3% Triton X-100 PBS and incubated with a
1:1,000 dilution of rabbit-anti-CRLR antibody (kindly provided by Nigel Bunnett/
Eileen Grady). The speciﬁcity of the antibody has previously been determined70
and was additionally conﬁrmed with preabsorption controls and omission of the
primary antibody. Images were taken using an Olympus BX60 Fluorescent
Microscope (Olympus, Melville, NY) with appropriate ﬁlter settings and software
packages (MetaSystems, Altlussheim, Germany).
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